NasdaqGS - Delayed Quote USD
Collegium Pharmaceutical, Inc. (COLL)
28.89
+1.62
+(5.94%)
At close: May 9 at 4:00:02 PM EDT
28.89
0.00
(0.00%)
After hours: May 9 at 4:05:12 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 518,689 | 10 |
| Sales | 195,524 | 11 |
| Net Shares Purchased (Sold) | 323,165 | 21 |
| Total Insider Shares Held | 464.13k | -- |
| % Net Shares Purchased (Sold) | 229.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DREYER SCOTT Officer | Sale at price 30.00 - 30.03 per share. | Direct | 624,794 | Mar 21, 2025 |
| TUPPER COLLEEN Chief Financial Officer | Sale at price 30.00 - 30.03 per share. | Direct | 228,250 | Mar 21, 2025 |
| DIETER DAVID General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2025 |
| DREYER SCOTT Officer | Sale at price 30.00 per share. | Direct | 67,661 | Mar 14, 2025 |
| TUPPER COLLEEN Chief Financial Officer | Sale at price 30.00 per share. | Direct | 29,313 | Mar 14, 2025 |
| DREYER SCOTT Officer | Sale at price 30.00 per share. | Direct | 461,672 | Mar 11, 2025 |
| TUPPER COLLEEN Chief Financial Officer | Sale at price 30.01 per share. | Direct | 313,413 | Mar 11, 2025 |
| DREYER SCOTT Officer | Sale at price 30.00 per share. | Direct | 169,299 | Mar 7, 2025 |
| TUPPER COLLEEN Chief Financial Officer | Sale at price 30.00 per share. | Direct | 103,591 | Mar 7, 2025 |
| KUHLMANN SHIRLEY R. General Counsel | Sale at price 28.03 - 28.50 per share. | Direct | 2,426,634 | Mar 6, 2025 |
| DREYER SCOTT Officer | Sale at price 30.00 per share. | Direct | 461,672 | Mar 6, 2025 |
| KUHLMANN SHIRLEY R. General Counsel | Conversion of Exercise of derivative security at price 24.03 per share. | Direct | 961,200 | Mar 4, 2025 |
| HEFFERNAN MICHAEL THOMAS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 10, 2025 |
| KUHLMANN SHIRLEY R. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 10, 2025 |
| DREYER SCOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 10, 2025 |
| SMITH THOMAS BRAIN M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 10, 2025 |
| TUPPER COLLEEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 10, 2025 |
| LURKER NANCY S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| KUHLMANN SHIRLEY R. General Counsel | Conversion of Exercise of derivative security at price 21.34 per share. | Direct | 586,850 | Jan 10, 2025 |
| KUHLMANN SHIRLEY R. General Counsel | Sale at price 32.87 - 33.64 per share. | Direct | 908,628 | Jan 10, 2025 |
| KARNANI VIKRAM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 12, 2024 |
| SMITH THOMAS BRAIN M.D. Officer | Sale at price 36.62 per share. | Direct | 351,320 | Sep 13, 2024 |
| KUHLMANN SHIRLEY R. General Counsel | Sale at price 37.46 - 39.14 per share. | Direct | 773,792 | Sep 6, 2024 |
| KUHLMANN SHIRLEY R. General Counsel | Sale at price 32.55 - 33.22 per share. | Direct | 814,180 | Jun 3, 2024 |
| TUPPER COLLEEN Chief Financial Officer | Sale at price 34.21 per share. | Direct | 674,368 | May 28, 2024 |
| DREYER SCOTT Officer | Conversion of Exercise of derivative security at price 24.03 per share. | Direct | 1,802,250 | May 24, 2024 |
| DREYER SCOTT Officer | Sale at price 33.82 - 33.98 per share. | Direct | 3,662,548 | May 24, 2024 |
| SANTINI GINO Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| BOHLIN GAREN G. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| FREUND JOHN GORDON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| HEFFERNAN MICHAEL THOMAS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| MELINCOFF GWEN A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| FALLON JOHN A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| MCFARLANE NEIL F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| BALICE-GORDON RITA J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| BOHLIN GAREN G. Director | Conversion of Exercise of derivative security at price 5.73 per share. | Direct | 166,084 | May 14, 2024 |
| BOHLIN GAREN G. Director | Sale at price 32.30 per share. | Direct | 936,311 | May 14, 2024 |
| SMITH THOMAS BRAIN M.D. Officer | Sale at price 36.76 per share. | Direct | 36,580 | Feb 29, 2024 |
| DREYER SCOTT Officer | Sale at price 36.38 - 37.15 per share. | Direct | 364,270 | Feb 26, 2024 |
| CIAFFONI JOSEPH J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| KUHLMANN SHIRLEY R. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| DREYER SCOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| SMITH THOMAS BRAIN M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| TUPPER COLLEEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| DREYER SCOTT Officer | Sale at price 32.28 per share. | Direct | 760,519 | Jan 16, 2024 |
| CIAFFONI JOSEPH J Chief Executive Officer | Conversion of Exercise of derivative security at price 21.34 per share. | Direct | 92,978 | Dec 21, 2023 |
| CIAFFONI JOSEPH J Chief Executive Officer | Sale at price 30.38 per share. | Direct | 132,377 | Dec 21, 2023 |
| CIAFFONI JOSEPH J Chief Executive Officer | Conversion of Exercise of derivative security at price 21.34 per share. | Direct | 1,467,509 | Dec 20, 2023 |
| CIAFFONI JOSEPH J Chief Executive Officer | Sale at price 30.03 - 30.40 per share. | Direct | 2,075,086 | Dec 20, 2023 |
| KUHLMANN SHIRLEY R. General Counsel | Conversion of Exercise of derivative security at price 15.90 per share. | Direct | 407,040 | Nov 27, 2023 |
Related Tickers
PCRX Pacira BioSciences, Inc.
25.12
+0.84%
SUPN Supernus Pharmaceuticals, Inc.
31.70
+0.51%
AMPH Amphastar Pharmaceuticals, Inc.
24.11
-2.19%
SIGA SIGA Technologies, Inc.
5.66
+4.04%
ANIK Anika Therapeutics, Inc.
11.64
-21.03%
PBH Prestige Consumer Healthcare Inc.
87.30
+0.30%
IRWD Ironwood Pharmaceuticals, Inc.
0.7092
+1.33%
HCM HUTCHMED (China) Limited
14.21
-2.27%
INDV Indivior PLC
11.08
+0.91%
ALKS Alkermes plc
30.13
-0.82%